ACMG
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
At the American College of Medical Genetics and Genomics annual meeting, NICHD Director Diana Bianchi reported that whole-body MRI was the best follow-up test to confirm or rule out cancer.
At the American College of Medical Genetics and Genomics annual meeting, members of two working groups provided an early look at new versions of the existing standards.
ACMG Asserts Evidence Insufficient for Clinical Utility of Polygenic Risk Scores for Embryo Testing
Premium
The risk of harm to prospective parents or future children outweighs the benefits of preimplantation genetic testing, an ACMG working group said.
ACMG Releases Statement on Biases Affecting Equitable Access to Clinical Genomics Testing
An ACMG working group recommends that the genetics community take action to limit the barriers to clinical genomics testing imposed by bias.